Biocon Foundation, the CSR arm of Biocon Group, has launched BioWISE – Women in STEM Empowered – a pioneering initiative to support women science students from underrepresented communities in Karnataka. In collaboration with The Bengaluru Scien...
Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware
.jpeg)
Parexel, a top-ranked international clinical research organisation (CRO), has formally registered with India's Central Drugs Standard Control Organisation (CDSCO), in line with the newly imposed G.S.R 581(E) regulation.
.jpeg)
neSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a multi-modality specialty pharma pure-play CDMO, announced that its flagship facility in Bangalore, India.
.jpeg)
Ahmedabad-based company, Cadila Pharmaceuticals, has entered the space of beta-blocker therapy by introducing Biscado (Bisoprolol), a notable milestone in the improvement of its portfolio in cardiac care.
 (1).png)
As a strategic enterprise to control antimicrobials' use in animals and include antimicrobial resistance (AMR), the Central Drugs Standard Control Organisation (CDSCO) will form a Joint Working Group.
The eye care company Alcon, leading worldwide, has made its PRECISION1 daily disposable contact lenses available in India. Lenses featuring SMARTSURFACE technology are now available, created for up to 16 hours of wearing comfort to satisfy the increa
.jpg)
India is considering imposing a Minimum Import Price (MIP) on critical components of medicines to cut the country's dependence on costlier Chinese imports and spur local production.
Roche has reported favorable outcomes from the Phase III IMforte trial involving Tecentriq (atezolizumab) in conjunction with lurbinectedin (Zepzelca®) as a first-line maintenance therapy
 (2).png)
Glenmark Pharmaceuticals has announced that it will shortly introduce zanubrutinib in India, soon after getting its recent approval from the Drugs Controller General of India (DCGI).
, CDSCO.jpg)
